Log in

NASDAQ:LXRXLexicon Pharmaceuticals News Headlines

$1.85
-0.08 (-4.15 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.85
Now: $1.85
$1.95
50-Day Range
$1.85
MA: $1.97
$2.19
52-Week Range
$1.13
Now: $1.85
$6.49
Volume850,500 shs
Average Volume839,140 shs
Market Capitalization$197.89 million
P/E Ratio2.98
Dividend YieldN/A
Beta1.16

Headlines

Lexicon Pharmaceuticals (NASDAQ LXRX) News Headlines

Source:
DateHeadline
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Short Interest Up 8.5% in JuneLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Short Interest Up 8.5% in June
www.americanbankingnews.com - July 8 at 5:01 AM
Should You Buy Lexicon Pharmaceuticals, Inc. (LXRX)?Should You Buy Lexicon Pharmaceuticals, Inc. (LXRX)?
finance.yahoo.com - July 4 at 7:04 PM
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Recommendation of "Hold" from AnalystsLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 26 at 1:17 AM
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Expected to Announce Quarterly Sales of $8.70 MillionLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Expected to Announce Quarterly Sales of $8.70 Million
www.americanbankingnews.com - June 22 at 9:08 AM
 Brokerages Expect Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) to Post -$0.57 Earnings Per Share Brokerages Expect Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) to Post -$0.57 Earnings Per Share
www.americanbankingnews.com - June 20 at 9:53 AM
Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl’s Antiproliferative Effects Against Various Cancer Cell LinesLexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl’s Antiproliferative Effects Against Various Cancer Cell Lines
finance.yahoo.com - May 13 at 6:11 PM
Edited Transcript of LXRX earnings conference call or presentation 27-Apr-20 12:00pm GMTEdited Transcript of LXRX earnings conference call or presentation 27-Apr-20 12:00pm GMT
finance.yahoo.com - May 2 at 1:12 AM
Why Lexicon Pharmaceuticals Stock Soared TodayWhy Lexicon Pharmaceuticals Stock Soared Today
www.fool.com - April 27 at 7:59 PM
Lexicon Pharmaceuticals Inc (LXRX) Q1 2020 Earnings Call TranscriptLexicon Pharmaceuticals Inc (LXRX) Q1 2020 Earnings Call Transcript
www.nasdaq.com - April 27 at 2:58 PM
Lexicon Pharmaceuticals EPS beats by $0.05, beats on revenueLexicon Pharmaceuticals EPS beats by $0.05, beats on revenue
seekingalpha.com - April 27 at 9:57 AM
Lexicon Pharma Xermelo sales up 17% in Q1Lexicon Pharma Xermelo sales up 17% in Q1
seekingalpha.com - April 27 at 9:57 AM
LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATELEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
finance.yahoo.com - April 27 at 9:57 AM
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Tops Revenue EstimatesLexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - April 27 at 9:57 AM
Lexicon Pharmaceuticals: Q1 Earnings InsightsLexicon Pharmaceuticals: Q1 Earnings Insights
feeds.benzinga.com - April 27 at 7:55 AM
Lexicon Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast On April 27, 2020Lexicon Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast On April 27, 2020
finance.yahoo.com - April 22 at 7:24 PM
The Lexicon Pharmaceuticals (NASDAQ:LXRX) Share Price Is Down 88% So Some Shareholders Are Rather UpsetThe Lexicon Pharmaceuticals (NASDAQ:LXRX) Share Price Is Down 88% So Some Shareholders Are Rather Upset
finance.yahoo.com - April 20 at 2:10 PM
Lexicon Pharmaceuticals IncLexicon Pharmaceuticals Inc
www.bloomberg.com - April 18 at 6:53 PM
LEXICON PHARMACEUTICALS TO HOST VIRTUAL ANNUAL MEETING OF STOCKHOLDERS ON APRIL 23, 2020LEXICON PHARMACEUTICALS TO HOST VIRTUAL ANNUAL MEETING OF STOCKHOLDERS ON APRIL 23, 2020
finance.yahoo.com - April 7 at 5:53 PM
Lexicon Pharmaceuticals Moving On From Diabetes And Pivoting Toward Clinical CandidatesLexicon Pharmaceuticals Moving On From Diabetes And Pivoting Toward Clinical Candidates
seekingalpha.com - March 24 at 1:25 PM
Mylans COVID-19 Medicine, And Other News: The Good, Bad And Ugly Of BiopharmaMylan's COVID-19 Medicine, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - March 22 at 8:11 AM
Lexicon shuts down two Zynquista studies due to funding issuesLexicon shuts down two Zynquista studies due to funding issues
seekingalpha.com - March 19 at 6:33 PM
LEXICON PHARMACEUTICALS PROVIDES AN UPDATE ON THE SOTAGLIFLOZIN TYPE 2 DIABETES PROGRAMLEXICON PHARMACEUTICALS PROVIDES AN UPDATE ON THE SOTAGLIFLOZIN TYPE 2 DIABETES PROGRAM
finance.yahoo.com - March 19 at 6:33 PM
LEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYLS ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROMELEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYL'S ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROME
www.benzinga.com - March 15 at 5:36 PM
Lexicon Pharma up 11% premarket on positive Xermelo dataLexicon Pharma up 11% premarket on positive Xermelo data
seekingalpha.com - March 13 at 1:46 PM
LEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYL’S ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROMELEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYL’S ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROME
finance.yahoo.com - March 13 at 8:45 AM
Edited Transcript of LXRX earnings conference call or presentation 12-Mar-20 12:00pm GMTEdited Transcript of LXRX earnings conference call or presentation 12-Mar-20 12:00pm GMT
finance.yahoo.com - March 12 at 11:53 PM
Lexicon Pharmaceuticals: Q4 Earnings InsightsLexicon Pharmaceuticals: Q4 Earnings Insights
finance.yahoo.com - March 12 at 6:53 PM
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Misses Revenue EstimatesLexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 12 at 1:52 PM
Lexicon Pharmaceuticals EPS beats by $0.29, misses on revenueLexicon Pharmaceuticals EPS beats by $0.29, misses on revenue
seekingalpha.com - March 12 at 8:52 AM
LEXICON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATELEXICON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
finance.yahoo.com - March 12 at 8:52 AM
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call and Webcast on March 12, 2020Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call and Webcast on March 12, 2020
finance.yahoo.com - March 5 at 10:40 AM
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - March 4 at 1:41 PM
Lexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethyl’s Antiproliferative Effects in Patients With Carcinoid SyndromeLexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethyl’s Antiproliferative Effects in Patients With Carcinoid Syndrome
finance.yahoo.com - January 24 at 3:42 PM
Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers SymposiumLexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium
www.benzinga.com - January 20 at 5:01 PM
Is Lexicon Pharmaceuticals (NASDAQ:LXRX) Using Too Much Debt?Is Lexicon Pharmaceuticals (NASDAQ:LXRX) Using Too Much Debt?
finance.yahoo.com - January 20 at 10:11 AM
Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceLexicon Pharmaceuticals to Present at Upcoming Investor Conference
www.benzinga.com - January 6 at 7:45 PM
Lexicon Needs More Than Incremental Positive Clinical DataLexicon Needs More Than Incremental Positive Clinical Data
seekingalpha.com - December 20 at 2:14 PM
Lexicon Pharmas Zynquista successful in late-stage T2D study; shares up 16% PMLexicon Pharma's Zynquista successful in late-stage T2D study; shares up 16% PM
seekingalpha.com - December 20 at 9:14 AM
Lexicon shares fall on diabetes study dataLexicon shares fall on diabetes study data
finance.yahoo.com - December 20 at 9:14 AM
Implied Volatility Surging for Lexicon (LXRX) Stock OptionsImplied Volatility Surging for Lexicon (LXRX) Stock Options
finance.yahoo.com - December 13 at 1:48 PM
Lexicon up 4% on positive early-stage data on neuropathic pain candidate LX9211Lexicon up 4% on positive early-stage data on neuropathic pain candidate LX9211
seekingalpha.com - December 5 at 1:22 PM
How Much is Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) CEO Getting Paid?How Much is Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) CEO Getting Paid?
finance.yahoo.com - December 5 at 1:22 PM
Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211
finance.yahoo.com - December 5 at 8:22 AM
Lexicon Pharma up 6% on advancement of biliary cancer candidateLexicon Pharma up 6% on advancement of biliary cancer candidate
seekingalpha.com - December 3 at 1:47 PM
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract CancerLexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer
finance.yahoo.com - December 3 at 8:46 AM
Why Roku, Ollies Bargain Outlet Holdings, and Lexicon Pharmaceuticals Slumped TodayWhy Roku, Ollie's Bargain Outlet Holdings, and Lexicon Pharmaceuticals Slumped Today
www.fool.com - December 2 at 5:12 PM
LXRX, APA among premarket losersLXRX, APA among premarket losers
seekingalpha.com - December 2 at 12:09 PM
Heres Why Lexicon Pharmaceuticals Is Tumbling TodayHere's Why Lexicon Pharmaceuticals Is Tumbling Today
www.fool.com - December 2 at 12:09 PM
Lexicon loses appeal of sotagliflozin CRL; shares down 10% premarketLexicon loses appeal of sotagliflozin CRL; shares down 10% premarket
seekingalpha.com - December 2 at 12:09 PM
Lexicon Pharma shares plummet after FDA denies appeal against drug rejectionLexicon Pharma shares plummet after FDA denies appeal against drug rejection
www.nasdaq.com - December 2 at 12:09 PM
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.